SERA
Closed
Sera Prognostics Inc
2.59
-0.18 (-6.50%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.77
Day's Range: 2.55 - 2.74
Send
sign up or login to leave a comment!
When Written:
3.81
Sera Prognostics Inc is a biotechnology company based in Salt Lake City, Utah, USA. The company is focused on developing innovative diagnostic tests for women's health, particularly in the areas of pregnancy and reproductive health.
Sera Prognostics' flagship product is the PreTRM® test, which is a blood test that predicts a woman's risk of preterm birth. The test measures specific proteins in the mother's blood that are associated with inflammation and other factors that can lead to preterm birth. The PreTRM® test is designed to help healthcare providers identify women who are at high risk of preterm birth and provide appropriate interventions to improve pregnancy outcomes.
Sera Prognostics was founded in 2008 and has raised over $100 million in funding from investors. The company has partnerships with several leading healthcare organizations, including the March of Dimes and the Perinatal Quality Foundation. Sera Prognostics is committed to improving maternal and fetal health outcomes through innovative diagnostic solutions.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Sera Prognostics' flagship product is the PreTRM® test, which is a blood test that predicts a woman's risk of preterm birth. The test measures specific proteins in the mother's blood that are associated with inflammation and other factors that can lead to preterm birth. The PreTRM® test is designed to help healthcare providers identify women who are at high risk of preterm birth and provide appropriate interventions to improve pregnancy outcomes.
Sera Prognostics was founded in 2008 and has raised over $100 million in funding from investors. The company has partnerships with several leading healthcare organizations, including the March of Dimes and the Perinatal Quality Foundation. Sera Prognostics is committed to improving maternal and fetal health outcomes through innovative diagnostic solutions.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!